INVESTABOT
Equity Research
XNYS · PHARMACEUTICAL PREPARATIONS
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
Abbvie (ABBV) had 1 Form 144 pre-sale notice filed on 2026-08-14. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
Abbvie (ABBV) had 1 Form 144 pre-sale notice filed on 2026-05-26. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
open-market Form 4 only - grants, exercises, tax withholding excluded
0 buyers - 1 unique sellers · 9 accumulating - 3 trimming - 1 unchanged
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| August 14, 2026 | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | OPTION_EXERCISE | 32,710 | $79 | ~$2.6M |
| August 14, 2026 | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | SELL | -32,710 | $250 | ~$8.2M |
| August 14, 2026 | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | OPTION_EXERCISE | -32,710 | — | — |
| June 30, 2026 | Rapp Edward J | — | GRANT | 134 | $252 | ~$34K |
| June 30, 2026 | Quaggin Susan E | — | GRANT | 62 | $252 | ~$16K |
| May 8, 2026 | Hart Brett J | — | GRANT | 1,118 | — | — |
| May 8, 2026 | Falk Thomas J | — | GRANT | 1,118 | — | — |
| May 8, 2026 | Waddell Frederick H | — | GRANT | 1,118 | — | — |
| May 8, 2026 | Roberts Rebecca B | — | GRANT | 1,118 | — | — |
| May 8, 2026 | Rapp Edward J | — | GRANT | 1,118 | — | — |
| May 8, 2026 | Quaggin Susan E | — | GRANT | 1,118 | — | — |
| May 8, 2026 | Meyer Melody B | — | GRANT | 1,118 | — | — |
| May 8, 2026 | Freyman Thomas C | — | GRANT | 1,118 | — | — |
| May 8, 2026 | Davis Jennifer L. | — | GRANT | 1,118 | — | — |
| May 8, 2026 | Burnside William H.L. | — | GRANT | 1,118 | — | — |
| May 8, 2026 | Austin Roxanne S | — | GRANT | 1,118 | — | — |
| March 31, 2026 | Quaggin Susan E | — | GRANT | 71 | $217 | ~$15K |
| March 31, 2026 | Rapp Edward J | — | GRANT | 155 | $217 | ~$34K |
| March 31, 2026 | Alpern Robert J | — | GRANT | 35 | $217 | ~$8K |
| March 4, 2026 | Purdue David Ryan | SVP, Controller | SELL | -5,230 | $234 | ~$1.2M |
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| Vanguard Group | 180,779,699 | ~$41.3B | — | January 29, 2026 |
| BlackRock | 149,488,412 | ~$37.6B | -0.8% | August 7, 2026 |
| BlackRock | 151,174,543 | ~$34.5B | — | February 12, 2026 |
| BlackRock | 150,749,625 | ~$32.8B | -0.3% | May 13, 2026 |
| BlackRock | 136,431,510 | ~$23.4B | — | August 13, 2024 |
| State Street | 82,596,748 | ~$20.8B | 1.7% | August 7, 2026 |
| State Street | 80,940,931 | ~$18.5B | — | February 13, 2026 |
| State Street | 81,217,516 | ~$17.7B | 0.3% | May 15, 2026 |
| JP Morgan Chase | 48,482,296 | ~$12.3B | -15.5% | August 12, 2026 |
| JP Morgan Chase | 57,405,291 | ~$12.2B | 8.0% | May 13, 2026 |
| JP Morgan Chase | 53,175,823 | ~$12.2B | — | February 11, 2026 |
| Morgan Stanley | 38,901,001 | ~$9.8B | 2.3% | August 13, 2026 |
| Morgan Stanley | 40,041,940 | ~$9.1B | — | May 27, 2026 |
| Morgan Stanley | 38,016,774 | ~$8.3B | -5.1% | May 15, 2026 |
| Fidelity (FMR) | 20,773,786 | ~$5.2B | -4.5% | August 13, 2026 |
| Fidelity (FMR) | 22,609,389 | ~$5.2B | — | February 17, 2026 |
| Fidelity (FMR) | 21,762,703 | ~$4.7B | -3.7% | May 15, 2026 |
| Goldman Sachs | 17,743,530 | ~$4.5B | 7.9% | August 14, 2026 |
| Goldman Sachs | 16,437,679 | ~$3.6B | 19.4% | May 15, 2026 |
| Goldman Sachs | 13,770,925 | ~$3.1B | — | March 25, 2026 |